Biochemical and clinical characteristics of creatine deficiency syndromes
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Creatine deficiency syndromes are a newly described group of inborn errors of creatine synthesis (arginine:glycine amidinotransferase (AGAT) deficiency and guanidinoacetate methyltransferase (GAMT) deficiency) and of creatine transport (creatine transporter (CRTR) deficiency). The common clinical feature of creatine deficiency syndromes is mental retardation and epilepsy suggesting main involvement of cerebral gray matter. The typical biochemical abnormality of creatine deficiency syndromes is cerebral creatine deficiency, which is demonstrated by in vivo proton magnetic resonance spectroscopy. Measurement of guanidinoacetate in body fluids may discriminate between the GAMT (high concentration), AGAT (low concentration) and CRTR (normal concentration) deficiencies. Further biochemical characteristics include changes in creatine and creatinine concentrations in body fluids. GAMT and AGAT deficiency are treatable by oral creatine supplementation, while patients with CRTR deficiency do not respond to this type of treatment. The creatine deficiency syndromes are underdiagnosed, so their possibility should be considered in all children affected by unexplained mental retardation, seizures and speech delay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This class of syndromes results in a reduction or inability to endogenously synthesize creatine leading low levels of creatine and phosphocreatine in the muscle and brain.”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some individuals have been found to have creatine synthesis deficiencies due to inborn errors in AGAT, GMAT and/or creatine transporter (CRTR) deficiencies and therefore must depend on dietary creatine intake in order to maintain normal muscle and brain concentrations of PCr and Cr”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The physical presentation of this scenario includes muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental development challenges, epilepsy, and other developmental problems (91–93)”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Individuals with creatine synthesis deficiencies have low levels of creatine and PCr in the muscle and the brain.”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [17]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K., & Hultman, E. (1993) · Clinical Science · doi:10.1042/cs0840565 · Cited by 460
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases
(2003) · Springer eBooks · doi:10.1007/978-3-642-55878-8 · Cited by 271
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man.
Stöckler, S., Isbrandt, D., Hanefeld, F. A., Schmidt, B., & FIGURA, K. V. (1996) · PubMed · Cited by 219
Schulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., Knopp, M. V., De Deyn, P. P., Bremer, H. J., & Rating, D. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70075-1 · Cited by 170
Reversible brain creatine deficiency in two sisters with normal blood creatine level
Bianchi, M. C., Tosetti, M., Fornai, F., Grazia Alessandri', M., Cipriani, P., De Vito, G., & Canapicchi, R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<511::aid-ana15>3.0.co;2-n · Cited by 148
Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism
Stromberger, C., Bodamer, O. A., & Stöckler‐Ipsiroglu, S. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024453704800 · Cited by 130
Self-citationStöckler, S., Marescau, B., Deyn, P. R. D., Trijbels, J. M. F., & Hanefeld, F. A. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90215-8 · Cited by 120
Research works printed but not linked: 2
- Item CB, Stöckler-Ipsiroglu S, Stromberger C et al. (2001) Arginine:glycine amidino- transferase (AGAT) deficiency: the third in- born error of creatine metabolism in hu- mans. Am J Hum Genet.; 69: 1127-33.
- Item CB, Mercimek-Mahmutoglu S, Battini R et al. (2004) Characterisation of seven novel mutations in seven patients with GAMT defi- ciency. Hum Mutat.; 23: 524.
Cited by
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
BackgroundFunctions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Brosnan, M. E., & Brosnan, J. T. (2016) · Amino Acids · doi:10.1007/s00726-016-2188-1 · Cited by 185
Genetic medicines: treatment strategies for hereditary disorders
O'Connor, T. P., & Crystal, R. G. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1829 · Cited by 180
Braissant, O., Henry, H., Villard, A.-M., Speer, O., Wallimann, T., & Bachmann, C. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-9 · Cited by 125
Creatine and Creatine Deficiency Syndromes: Biochemical and Clinical Aspects
Nasrallah, F., Feki, M., & Kaabachi, N. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.07.015 · Cited by 116
Braissant, O., & Henry, H. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0826-9 · Cited by 116
Expression and Function of Agat, Gamt and CT1 in the Mammalian Brain
Braissant, O., Bachmann, C., & Henry, H. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_4 · Cited by 94
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency
Dhar, S. U., Scaglia, F., Li, F.-Y., Smith, L. D., Barshop, B. A., Eng, C. M., Haas, R., Hunter, J. V., Lotze, T. E., Maranda, B., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.10.008 · Cited by 81
Wallimann, T., Tokarska‐Schlattner, M., Neumann, D., Epand, R. M., Epand, R. F., Andres, R. H., Widmer, H. R., Hornemann, T., Saks, V., Agarkova, I., et al. (2007) · Molecular System Bioenergetics · doi:10.1002/9783527621095.ch7 · Cited by 80
The therapeutic role of creatine in Huntington's disease
Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.008 · Cited by 79
Autism Spectrum Disorders and Inborn Errors of Metabolism: An Update
Ghaziuddin, M., & Al‐Owain, M. A. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.05.013 · Cited by 80
Metabolomic approach to profile functional and metabolic changes in heart failure
Deidda, M., Piras, C., Dessalvi, C. C., Locci, E., Barberini, L., Torri, F., Ascedu, F., Atzori, L., & Mercuro, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0661-3 · Cited by 72
Zugno, A. I., Stefanello, F. M., Scherer, E. B. S., Mattos, C., Pederzolli, C. D., de Andrade, V. M., Wannmacher, C. M. D., Wajner, M., Dutra‐Filho, C. S., & Wyse, Â. T. D. S. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9636-6 · Cited by 66
Ireland, Z., Russell, A. P., Wallimann, T., Walker, D. W., & Snow, R. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-39 · Cited by 63
The Neuroprotective Role of Creatine
Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 63
Synaptic determinants of Rett syndrome
Boggio (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00028 · Cited by 57
D3‐creatine dilution for skeletal muscle mass measurement: historical development and current status
McCarthy, C., Schoeller, D., Brown, J. C., Gonzalez, M. C., Varanoske, A. N., Cataldi, D., Shepherd, J., & Heymsfield, S. B. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13083 · Cited by 50
Ingwall, J. S. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0023-x · Cited by 50
Carling, R. S., Hogg, S. L., Wood, T. C., & Calvin, J. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008029 · Cited by 50
Creatine metabolism differs between mammals and rainbow trout (Oncorhynchus mykiss)
Borchel, A., Verleih, M., Rebl, A., Kühn, C., & Goldammer, T. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-510 · Cited by 47
Cheillan, D., Curt, M. J.-C., Briand, G., Salomons, G. S., Mention-Mulliez, K., Dobbelaere, D., Cuisset, J.-M., Lion-François, L., Portes, V. D., Chabli, A., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-96 · Cited by 45
Cardinal, R. N., & Bullmore, E. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511686917 · Cited by 44
Movement disorders in neuro-metabolic diseases
Gouider‐Khouja, N., Kraoua, I., Benrhouma, H., Fraj, N., & Rouissi, A. (2009) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2009.11.005 · Cited by 43
Creatine and guanidinoacetate reference values in a French population
Curt, M. J.-C., Cheillan, D., Briand, G., Salomons, G. S., Mention-Mulliez, K., Dobbelaere, D., Cuisset, J., Lion‐François, L., Portes, V. D., Chabli, A., et al. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.09.005 · Cited by 42
Aitken, K. J. (2008) · The Keio Journal of Medicine · doi:10.2302/kjm.57.15 · Cited by 38
Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review
Jagim, A. R., Stecker, R. A., Harty, P. S., Erickson, J. L., & Kerksick, C. M. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00115 · Cited by 35
1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency
Dezortová, M., Jírů, F., Petrášek, J., Malinová, V., Zeman, J., Jirsa, M., & Hájek, M. (2008) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-008-0137-z · Cited by 34
Zugno, A. I., Scherer, E. B. S., Mattos, C., Ribeiro, C. A. J., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.005 · Cited by 27
Wang, L., Zhang, Y., Shao, M., & Zhang, H. (2007) · The International Journal of Developmental Biology · doi:10.1387/ijdb.062218lw · Cited by 25
Holden, B., & Guice, E. A. (2014) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12386 · Cited by 24
Severe Speech Delay as the Presenting Symptom of Guanidinoacetate Methyltransferase Deficiency
Vodopiutz, J., Item, C. B., Häusler, M., Korall, H., & Bodamer, O. A. (2007) · Journal of Child Neurology · doi:10.1177/0883073807304015 · Cited by 18
Finding new etiologies of mental retardation and hypotonia: X marks the spot
Rogers, R. C., Stevenson, R. E., Simensen, R. J., Holden, K. R., & Schwartz, C. E. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2007.02022.x · Cited by 15
Wang, L., Angley, M. T., Sorich, M. J., Young, R. L., McKinnon, R. A., & Gerber, C. (2010) · Autism Research · doi:10.1002/aur.145 · Cited by 14
Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness
Lugenbiel, P., Sartorius, A., Vollmayr, B., & Schloss, P. D. (2009) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903131597 · Cited by 14
Preclinical and clinical developments in enzyme-loaded red blood cells: an update
Bianchi, M., Rossi, L., Pierigè, F., Biagiotti, S., Bregalda, A., Tasini, F., & Magnani, M. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2219890 · Cited by 13
Creatine metabolism: detection of creatine and guanidinoacetate in saliva of healthy subjects.
Martínez, L. D., Bezard, M., Brunotto, M. N., & de Kremer, R. D. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 12
Síndromes de Deficiência Cerebral de Creatina
Malheiro, R., Diogo, L. M., Garcia, P., Fineza, I., & Oliveira, G. (2013) · Acta Médica Portuguesa · doi:10.20344/amp.1355 · Cited by 11
Kale, V. P., Wallery, J., Novak, J., Gibbs, S. T., Bourdi, M., Minh‐Ha, T., McKew, J. C., & Terse, P. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104750 · Cited by 9
Suplementação de creatina: efeitos ergogênicos e terapêuticos
Câmara, L. C., & Ritti‐Dias, R. M. (2009) · Revista de Medicina · doi:10.11606/issn.1679-9836.v88i2p94-102 · Cited by 6
Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study
Verduci, E., Carbone, M. T., Fiori, L., Gualdi, C., Banderali, G., Carducci, C., Leuzzi, V., Biasucci, G., & Zuccotti, G. (2021) · Life · doi:10.3390/life11050425 · Cited by 5
Spanevello, R. M., Wyse, Â. T. D. S., Mazzanti, C. M. D. A., Schmatz, R., Stefanello, N., Gonçalves, J. F., Bagatini, M. D., Battisti, V., Morsch, V. M., & Schetinger, M. R. C. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9561-0 · Cited by 4
Lin, H., Tan, B., Chi, S., & Yang, Q. (2025) · Aquaculture Nutrition · doi:10.1155/anu/5538869 · Cited by 4
Wallery, J. J., Kale, V. P., Novak, J., Gibbs, S. T., Minh‐Ha, T., McKew, J. C., & Terse, P. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115680 · Cited by 4
Energetic Basis for Heart Failure
Ingwall, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10007-5 · Cited by 4
Determination of radical scavenging activity of Creatine lysinate against methanol solutions of ABTS
Tsvetkova, D. D., Kostadinova, I., Vezenkov, L., & Marinov, L. (2023) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/y35odxrlw0 · Cited by 3
Phosphotransfer Reactions in the Failing Heart
Ingwall, J. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_2 · Cited by 3
Défice cognitivo por defeito da síntese de creatina
Loureiro, S., Gata, L., Almeida, J., Lontro, R., Diogo, L. M., & Oliveira, G. (2014) · Portuguese Journal of Pediatrics · doi:10.25754/pjp.2010.4360 · Cited by 3
Wang, L., Chen, D., Zhang, Y., Lin, Y., Li, J., & Zhang, H. (2008) · Development Genes and Evolution · doi:10.1007/s00427-008-0241-0 · Cited by 3
"A Narrative Review On Athletic Performance And Safety Of Creatine Supplementation For Adolescents"
Machado, M. (2022) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000419 · Cited by 2
X-Linked Cerebral Creatine Deficiency Syndrome with Prolonged QT Interval: A Case Report
Kim, H. W., Park, J. K., Lee, J. E., Lee, K. S., & Lee, B. L. (2022) · Annals of Child Neurology · doi:10.26815/acn.2022.00031 · Cited by 2
Glial mechanisms of axonal growth protection from ammonia
Braissant, O., Henry, H., Cagnon, L., Honegger, P., & Bachmann, C. (2007) · Springer eBooks · doi:10.1007/1-4020-4456-9_8 · Cited by 2
Fojut-Pałka, B., & Winnicka, A. (2008) · PubMed · Cited by 2
Creatine synthesis and methionine partitioning during TPN in Yucatan miniature piglets
Bray, S. D. (2017) · Memorial University Research Repository (Memorial University) · Cited by 1
Braissant, O., Henry, H., Villard, A.-M., Speer, O., Wallimann, T., & Bachmann, C. (2005) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005046489 · Cited by 1
Zugno, A. I. (2007) · Americanae (AECID Library)
Síndromes de Deficiência Cerebral de Creatina Cerebral Creatine Deficiency Syndromes
Malheiro, R., Diogo, L. M., Garcia, P., Fineza, I., & Oliveira, G. (2012)
Evaluation of Renal Function Test in Body Building
Kamash, Z. A., Faisal, A. H., & Dakhil, Z. F. (2026) · SAR Journal of Pathology and Microbiology · doi:10.36346/sarjpm.2026.v07i02.011
Byford-Pothan, J. (2025) · Otago University Research Archive (University of Otago)
Φυτοιστρογόνα και υγεία του παιδιού
Pons, R. (2008)
An investigation of potential biomarkers in children with autism spectrum disorder
Wang, L. (. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Síndromas de deficiência de creatina cerebral
Malheiro, R. C. A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Magni, D. V. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
POLI, M. E. (2016) · Electronic Theses and Dissertations Repository (University of Pisa)
Yasadışı ve Kötüye Kullanılan Madde Analizinde İdrar Bütünlük Testlerinin İncelenmesi
Çakırca, G., & Bozdayı, M. A. (2024) · Journal of Turkish Clinical Biochemistry · doi:10.56615/tkbd.2024.11
Défice do Transportador da Creatinia: quais os candidatos ao rastreio?
Marques, R. P. D. C. S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/3sxg-me73
Metadata
- Authors
- Sykut-Cegielska, J., Gradowska, W., Mercimek-Mahmutoglu, S., & Stöckler-Ipsiroglu, S.
- Affiliations
- University of Vienna (AT)
- Venue
- Acta Biochimica Polonica
- Publisher
- Frontiers Media SA
- Published
- 2004-12-31
- Volume
- 51
- Issue
- 4
- Pages
- 875-882
- ISSN
- 0001-527X (ISSN-L)
- 1734-154X
- OpenAlex
- W2067360430
- Cited by
- 60
- References
- 20
- Citations by year
- 2025: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-sa
- Locations
- Acta Biochimica Polonica (publishedVersion, cc-by-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- creatine deficiency syndrome, guanidinoacetate methyltransferase deficiency, creatine transporter deficiency, guanidinoacetic acid, intellectual disability, epilepsy, creatine supplementation, 1H NMR, underdiagnosis
- MeSH terms
- Amidinotransferases, Amino Acid Metabolism, Inborn Errors, Creatine, Humans, Methyltransferases, Membrane Transport Proteins, Guanidinoacetate N-Methyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.